JHE is a canine hemangiosarcoma cell line derived from a tumor in the heart of a 12-year old neutered male Golden Retriever with disseminated, metastatic disease. It grows in vitro.
Hemangiosarcoma is a rapidly growing, highly invasive variety of cancer, occurring commonly in dogs. It is a sarcoma arising from the lining of blood vessels. A frequent cause of death is the rupturing of this tumor, causing the patient to rapidly bleed to death.
From the laboratory of Jaime F. Modiano, VMD, PhD, University Minnesota, Twin Cities.
This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.
|Product Type:||Cell Line|
|Subculturing:||Split 1:2-1:4 when cells reach ~80% confluence|
|Growth Conditions:||Ham's F12, 10% FBS, 0.05mg/ml ECGS, 0.01mg/ml heparin, 10mM HEPES Buffer, 100ug/ml Primocin|
If you publish research with this product, please let us know so we can cite your paper.